ABOUT Viwit
With high-quality products and services, we continue to create more value for our customers, employees, shareholders and society, and contribute our talents and efforts to a healthier and better life
COMPANY PROFILE
Viwit Pharmaceuticals
𝗙𝗿𝗼𝗺 𝗠𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝘁𝗼 𝗖𝗲𝗹𝗹𝘂𝗹𝗮𝗿 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻
~𝘍𝘳𝘰𝘮 𝘊𝘩𝘪𝘳𝘢𝘭 Borane 𝘊𝘩𝘦𝘮𝘪𝘴𝘵𝘳𝘺 𝘵𝘰 𝘗𝘳𝘦𝘤𝘪𝘴𝘪𝘰𝘯 𝘋𝘦𝘭𝘪𝘷𝘦𝘳𝘺 𝘧𝘰𝘳 𝘐𝘯 𝘝𝘪𝘷𝘰 𝘊𝘦𝘭𝘭 𝘌𝘯𝘨𝘪𝘯𝘦𝘦𝘳𝘪𝘯𝘨
Viwit Pharmaceuticals is an innovation-driven biopharmaceutical and healthcare company with fully integrated capabilities across research and development, manufacturing, and commercialization.
Viwit’s journey began with chiral borane-based chemistry and has since evolved into a comprehensive platform covering chiral API and drug product development and manufacturing. Today, Viwit operates three integrated R&D centers and three cGMP manufacturing facilities, all approved by both the 𝗨𝗦 𝗙𝗗𝗔 𝗮𝗻𝗱 𝗖𝗵𝗶𝗻𝗮 𝗡𝗠𝗣𝗔.
Building on this foundation of 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗮𝗿 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻, Viwit is advancing toward a new generation of precision therapeutics centered on targeted delivery. In 2026, the company launched strategic programs in targeted cell therapies, with initial research focused on transformative platform: targeted lipid nanoparticles (tLNP) for mRNA and siRNA. By precisely delivering therapeutic payloads to selected cells in vivo, Viwit aims to enable 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗶𝗻 𝘃𝗶𝘃𝗼 𝗰𝗲𝗹𝗹 𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 and develop a new generation of therapies for 𝗰𝗮𝗻𝗰𝗲𝗿, 𝗮𝘂𝘁𝗼𝗶𝗺𝗺𝘂𝗻𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀, 𝗶𝗺𝗺𝘂𝗻𝗲 𝗿𝗲𝗷𝘂𝘃𝗲𝗻𝗮𝘁𝗶𝗼𝗻, and other areas of significant unmet medical need.
PRODUCT INTRODUCTION
We are committed to developing into a global leading medical and health enterprise based on the overall competitive advantage of the industrial chain and based on technological innovation
Drug Products
Cardiovascular drugs
Anti-infective drugs
Anti-inflammatory analgesics
Anti-viral drugs
CNS medication
HIGH DEMAND PRODUCTS
Adhering to customer demand, building core competitiveness, and striving to provide better and higher quality health products and services
INNOVATION
& collaboration platform
CDMO
Viwit platform provides CDMO services of APIs and intermediates, oral solids (tablets, capsules), sterile liquid products (small volume injections-ampoules, vials, eye drops).
View More +
Project Collaboration
Viwit platform provides R&D project cooperation and commercialization, covering the entire pharma industrial value chain from finished drugs to APIs.
View More +
In-/Out-Licensing
Viwit is dedicated to developing and providing innovative, valuable drugs to the general public and assisting our business partners to bring high-quality products to global markets.
View More +
BLOG CENTER
Make due contribution to the development of the industry and society, and strive to become the pacesetter and pioneer of the industry.
中文
EN